Annexon, Inc. (ANNX)
ANNX Stock Price Chart
Explore Annexon, Inc. interactive price chart. Choose custom timeframes to analyze ANNX price movements and trends.
ANNX Company Profile
Discover essential business fundamentals and corporate details for Annexon, Inc. (ANNX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Jul 2020
Employees
96.00
Website
https://www.annexonbio.comCEO
Douglas E. Love
Description
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway. The company targets this pathway to address specific disease mechanisms, such as those seen in antibody-mediated autoimmune disorders and complement-driven neurodegeneration. The company's developmental pipeline features several promising candidates. ANX005, a monoclonal antibody, is in advanced clinical testing, undergoing Phase II/III trials for Guillain-Barré syndrome, as well as Phase II trials for warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis. Another candidate, ANX009, is currently in Phase Ib studies for lupus nephritis. Additionally, ANX007 is progressing through Phase II clinical trials for the treatment of geographic atrophy, an eye disease. Further investigational assets include ANX105, a monoclonal antibody being developed for neurodegenerative indications, and ANX1502, an oral small molecule under investigation for specific autoimmune conditions. Annexon, Inc. was established in 2011 and operates from its headquarters in Brisbane, California.
ANNX Financial Timeline
Browse a chronological timeline of Annexon, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.23, while revenue estimate is $6.50m.
Earnings released on 7 May 2026
EPS came in at -$0.23 surpassing the estimated -$0.30 by +23.33%.
Earnings released on 30 Mar 2026
EPS came in at -$0.28 surpassing the estimated -$0.32 by +12.50%.
Earnings released on 10 Nov 2025
EPS came in at -$0.37 falling short of the estimated -$0.34 by -8.82%.
Earnings released on 14 Aug 2025
EPS came in at -$0.34 surpassing the estimated -$0.36 by +5.56%.
Earnings released on 12 May 2025
EPS came in at -$0.37 falling short of the estimated -$0.30 by -23.33%.
Earnings released on 3 Mar 2025
EPS came in at -$0.33 falling short of the estimated -$0.28 by -17.86%.
Earnings released on 14 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%.
Earnings released on 12 Aug 2024
EPS came in at -$0.23 matching the estimated -$0.23.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.32 by +34.38%.
Earnings released on 26 Mar 2024
EPS came in at -$0.36 surpassing the estimated -$0.45 by +20.00%, while revenue for the quarter reached $4.87m .
Earnings released on 13 Nov 2023
EPS came in at -$0.43 surpassing the estimated -$0.50 by +14.00%.
Earnings released on 7 Aug 2023
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%.
Earnings released on 8 May 2023
EPS came in at -$0.52 matching the estimated -$0.52.
Earnings released on 6 Mar 2023
EPS came in at -$0.48 surpassing the estimated -$0.52 by +7.69%.
Earnings released on 3 Nov 2022
EPS came in at -$0.51 surpassing the estimated -$0.87 by +41.38%.
Earnings released on 8 Aug 2022
EPS came in at -$0.96 falling short of the estimated -$0.94 by -2.13%.
Earnings released on 9 May 2022
EPS came in at -$0.92 surpassing the estimated -$1.00 by +8.00%.
Earnings released on 1 Mar 2022
EPS came in at -$0.97 falling short of the estimated -$0.90 by -7.78%.
Earnings released on 9 Nov 2021
EPS came in at -$0.93 falling short of the estimated -$0.88 by -5.68%.
Earnings released on 16 Aug 2021
EPS came in at -$0.82 falling short of the estimated -$0.68 by -20.59%.
ANNX Stock Performance
Access detailed ANNX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
